Tag:

Prime Minister Modi

Indian Government Regulations for Pharmaceuticals Pharmacy Manufacturing
Resistance to Reform: Punjab Pharmaceutical Manufacturers Push Back Against Modi’s Schedule M Mandate

by Brian Rogers June 4, 2024

by Brian Rogers June 4, 2024

Prime Minister Narendra Modi’s directive for Indian pharmaceutical plants to achieve WHO GMP certification by …

Read more
Indian Government Regulations for Pharmaceuticals
A New Era for Indian Pharma: WHO Certification Mandate by End of 2023

by Brian Rogers June 4, 2024

by Brian Rogers June 4, 2024

Prime Minister Narendra Modi has set a transformative goal for India’s pharmaceutical industry: by the …

Read more

Not-For-Profit Affordable Healthcare and Pharmaceutical Advocacy

Ashvin Medicara is committed to promoting health equity by educating the public about generic medications and advocating for affordable healthcare. We welcome the opportunity to collaborate with the Food and Drug Administration (FDA), U.S. Customs and Border Protection (CBP), U.S. Congress, Drug Enforcement Administration (DEA), and Indian pharmacy groups such as the Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers' Association (IDMA), Pharmaceuticals Export Promotion Council of India (Pharmexcil), Central Drugs Standard Control Organization (CDSCO), and the Department of Pharmaceuticals, ensuring we find a middle ground to deliver quality medications within the bounds of the law.

00:00

Queue

Update Required Flash plugin

00:00